Gastrointestinal Cancer News

Postmenopausal women who consumed at least one sugar-sweetened soft drink per day had significantly higher incidence of liver cancer and chronic liver disease mortality, compared with those who drank no more than three beverages per month.

A novel therapeutic approach that combined radiation and immunotherapy demonstrated the ability to eliminate pancreatic tumors and halt metastases.

A meta-analysis performed by an international group of researchers revealed no association between depression or anxiety and increased overall cancer risk.

Time from presentation to treatment did not affect survival among adults aged younger than 50 years with colorectal cancer, according to study results published in JAMA Network Open.

Surgery did not significantly increase the number of “good days” among patients with advanced cancer and malignant small bowel obstruction, according to study results.

The rate of new cancer diagnoses among adults declined sharply in the early days of the COVID-19 pandemic, according to study results published in The Lancet Oncology.

The FDA approved trifluridine and tipiracil with bevacizumab for patients with previously treated metastatic colorectal cancer.

A multitarget stool DNA methylation assay accurately detected and identified the tissue of origin for multiple gastrointestinal cancers, according to study results presented at ASCO Breakthrough.

The FDA granted 510(k) clearance to Magentiq Eye’s artificial intelligence-aided software for real-time detection of gastrointestinal lesions during colonoscopy, according to a company press release.

The ACP recently issued guidance that recommends colorectal cancer screening in asymptomatic, average-risk adults starting at age 50 years, going against some other organizations that recommend screening at an earlier age.